ATE307586T1 - Hemmung von mit gewebetrauma verbundenen pathogenen prozessen - Google Patents

Hemmung von mit gewebetrauma verbundenen pathogenen prozessen

Info

Publication number
ATE307586T1
ATE307586T1 AT99936952T AT99936952T ATE307586T1 AT E307586 T1 ATE307586 T1 AT E307586T1 AT 99936952 T AT99936952 T AT 99936952T AT 99936952 T AT99936952 T AT 99936952T AT E307586 T1 ATE307586 T1 AT E307586T1
Authority
AT
Austria
Prior art keywords
group
effector
pharmaceutically acceptable
tissue trauma
hydrogen
Prior art date
Application number
AT99936952T
Other languages
English (en)
Inventor
Mark Pines
Israel Vlodavsky
Arnon Nagler
Eli Hazum
Original Assignee
Hadasit Med Res Service
Agricultural Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service, Agricultural Res Org filed Critical Hadasit Med Res Service
Application granted granted Critical
Publication of ATE307586T1 publication Critical patent/ATE307586T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99936952T 1998-08-13 1999-08-13 Hemmung von mit gewebetrauma verbundenen pathogenen prozessen ATE307586T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12579098 1998-08-13
US13714599P 1999-06-01 1999-06-01
PCT/IL1999/000440 WO2000009070A2 (en) 1998-08-13 1999-08-13 Inhibition of pathogenic processes related to tissue trauma

Publications (1)

Publication Number Publication Date
ATE307586T1 true ATE307586T1 (de) 2005-11-15

Family

ID=26323693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99936952T ATE307586T1 (de) 1998-08-13 1999-08-13 Hemmung von mit gewebetrauma verbundenen pathogenen prozessen

Country Status (8)

Country Link
EP (1) EP1109559B1 (de)
JP (1) JP2002522462A (de)
AT (1) ATE307586T1 (de)
AU (1) AU756437B2 (de)
CA (1) CA2340176A1 (de)
DE (1) DE69927987T2 (de)
ES (1) ES2255286T3 (de)
WO (1) WO2000009070A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143366A0 (en) * 2001-05-24 2002-04-21 Harasit Medical Res Services & Treatment of renal fibrosis
WO2004039308A2 (en) * 2002-10-31 2004-05-13 State Of Israel, Ministry Of Agriculture Quinazolinone compositions for regulation of gene expression related to pathological processes
RU2243778C2 (ru) * 2003-02-18 2005-01-10 Московский городской научно-исследовательский институт скорой помощи им. Н.В. Склифосовского Способ лечения последствий травматического и интраоперационного повреждения тканей у больных с политравмой
WO2007120606A2 (en) 2006-04-10 2007-10-25 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
ES2447834T3 (es) 2007-01-21 2014-03-13 Agricultural Research Organization Composición y método para tratar o prevenir la fibrosis del músculo esquelético
EP2331525A4 (de) 2008-08-11 2013-01-02 Harvard College Halofuginonanaloga zur inhibierung von trna-synthetasen und anwendungen davon
WO2012108538A1 (ja) 2011-02-10 2012-08-16 国立大学法人 長崎大学 急性肺損傷診断方法
EP2802572B1 (de) 2012-01-13 2018-11-07 President and Fellows of Harvard College Halofuginol-derivate und ihre verwendung in kosmetischen und pharmazeutischen zusammensetzungen
US11708353B2 (en) 2018-06-08 2023-07-25 The General Hospital Corporation Inhibitors of prolyl-tRNA-synthetase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
JPH08510251A (ja) * 1993-05-07 1996-10-29 ビー マーゴリン、ソロモン 線維症の病変の修復と予防のための組成物および方法
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
JPH0971586A (ja) * 1995-09-07 1997-03-18 Yamanouchi Pharmaceut Co Ltd 新規な二環性縮合イミダゾール誘導体
JP4027984B2 (ja) * 1996-07-03 2007-12-26 ユニヴェルシテ ド リエージュ 組換えn―プロテイナーゼ、及びその製造、方法及び使用
PT930876E (pt) * 1996-07-22 2005-01-31 Renovo Ltd Utilizacao de moduladores da funcao esteroide sexual para tratar feridas e desordens fibroticas
DK0941108T3 (da) * 1996-12-04 2002-11-18 Renovo Ltd Sårheling og behandling af fibrose
US5852024A (en) * 1997-02-11 1998-12-22 Hadasit Treatment and prevention of adhesions
US6028075A (en) * 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
DE19951702A1 (de) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten

Also Published As

Publication number Publication date
EP1109559A2 (de) 2001-06-27
JP2002522462A (ja) 2002-07-23
EP1109559A4 (de) 2002-05-08
ES2255286T3 (es) 2006-06-16
WO2000009070A2 (en) 2000-02-24
AU5191499A (en) 2000-03-06
DE69927987D1 (de) 2005-12-01
CA2340176A1 (en) 2000-02-24
WO2000009070A3 (en) 2000-10-19
EP1109559B1 (de) 2005-10-26
AU756437B2 (en) 2003-01-16
DE69927987T2 (de) 2006-11-09

Similar Documents

Publication Publication Date Title
BR0213129A (pt) Pró-drogas de compostos policìclicos substituìdos, úteis para inibição seletiva da cascata da coagulação
WO2001019798A3 (en) Inhibitors of factor xa
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
BRPI0409417A (pt) método para usar um composto, composto, e, composição
BR0008202A (pt) Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
ES2194986T3 (es) Compuestos de carbonil-piperazinilo y piperidinilo que inhiben la farnesil-protein-transferasa.
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
WO2000071511A3 (en) INHIBITORS OF FACTOR Xa
DE69724811D1 (de) Pentafluorobenzensulfonamide und analoge
BR9811099A (pt) Inibidores de urocinase
NO304891B1 (no) Steroidderivater for behandling av prostatahypertrofi
DE60141520D1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
ATE307586T1 (de) Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
ES2123873T3 (es) Pirrolocarbazol.
NZ506497A (en) Indole derivatives, pharmaceuticals thereof and their use in lowering intraocular pressure or for the treatment or prevention of glaucoma or ocular hypertension
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
NO20010654D0 (no) Ny anvendelse av taxoidderivater
KR970702273A (ko) 인돌 유도체 및 이를 함유하는 제제(indole derivative and medicine containing the same)
DE69232143D1 (de) Verwendung von Amlexanox zur Herstellung eines Arzneimittels zur Behandlung von aphtösen Ulcera
EP1418910A4 (de) Verfahren zur unterdrückung oder umkehrung der tau-filament-bildungspolymerisation
ES2195352T3 (es) Ureas ciclicas de benzo(5,6)cicloheptapiridina y lactamas utiles como inhibidores de la farnesil-protein-transferasa.
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
DK0912568T3 (da) Imidazopyridiner

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties